BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 30237140)

  • 1. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
    Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
    Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and characterization of a genetic Parkinson's disease-patient derived iPSC line DJ-1-delP (LCSBi008-A).
    Mencke P; Boussaad I; Önal G; Kievit AJA; Boon AJW; Mandemakers W; Bonifati V; Krüger R
    Stem Cell Res; 2022 Jul; 62():102792. PubMed ID: 35500378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of CHCHD2 gene in familial Parkinson's disease from Calabria.
    Gagliardi M; Iannello G; Colica C; Annesi G; Quattrone A
    Neurobiol Aging; 2017 Feb; 50():169.e5-169.e6. PubMed ID: 27839905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study.
    Funayama M; Ohe K; Amo T; Furuya N; Yamaguchi J; Saiki S; Li Y; Ogaki K; Ando M; Yoshino H; Tomiyama H; Nishioka K; Hasegawa K; Saiki H; Satake W; Mogushi K; Sasaki R; Kokubo Y; Kuzuhara S; Toda T; Mizuno Y; Uchiyama Y; Ohno K; Hattori N
    Lancet Neurol; 2015 Mar; 14(3):274-82. PubMed ID: 25662902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of a human iPSC line from an early-onset Parkinson's disease patient with a novel CHCHD2 gene truncated mutation.
    Jiang Z; Gu XJ; Su WM; Duan QQ; Lin JY; Cao B; Shang HF; Chen YP
    Stem Cell Res; 2022 Oct; 64():102881. PubMed ID: 35944313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a human induced pluripotent stem cell line (CSC-40) from a Parkinson's disease patient with a PINK1 p.Q456X mutation.
    Russ K; Marote A; Savchenko E; Collin A; Goldwurm S; Pomeshchik Y; Roybon L
    Stem Cell Res; 2018 Mar; 27():61-64. PubMed ID: 29331938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease.
    Savchenko E; Marote A; Russ K; Collin A; Goldwurm S; Roybon L; Pomeshchik Y
    Stem Cell Res; 2018 Mar; 27():78-81. PubMed ID: 29334629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHCHD2 gene mutations in familial and sporadic Parkinson's disease.
    Shi CH; Mao CY; Zhang SY; Yang J; Song B; Wu P; Zuo CT; Liu YT; Ji Y; Yang ZH; Wu J; Zhuang ZP; Xu YM
    Neurobiol Aging; 2016 Feb; 38():217.e9-217.e13. PubMed ID: 26705026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and characterization of human induced pluripotent stem cell line from a Parkinson's disease patient harboring VPS13A gene mutation.
    Lu X; Wang W; Liu Y; Song N; Li M; Mu X; Zhang N; Chen Q; Jiang L; Kong X; Sun P; Tong J; Zhang Y; Li J; Ma S; Han F
    Stem Cell Res; 2022 Apr; 60():102685. PubMed ID: 35093716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of induced pluripotent stem cell line(ZZUi006-A)from a patient with myotonic dystrophy type 1.
    Wang Y; Wang Z; Sun H; Shi C; Yang J; Liu Y; Liu H; Zhang S; Zhang L; Xu Y; Zhang J
    Stem Cell Res; 2018 Oct; 32():61-64. PubMed ID: 30216892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene.
    Gustavsson N; Marote A; Pomeshchik Y; Russ K; Azevedo C; Chumarina M; Goldwurm S; Collin A; Pinto L; Salgado AJ; Klementieva O; Roybon L; Savchenko E
    Stem Cell Res; 2019 Jan; 34():101373. PubMed ID: 30640063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analysis of CHCHD2 gene in Chinese Han familial essential tremor patients and familial Parkinson's disease patients.
    Gao C; Chen YM; Sun Q; He YC; Huang P; Wang T; Li DH; Liang L; Liu J; Xiao Q; Chen SD
    Neurobiol Aging; 2017 Jan; 49():218.e9-218.e11. PubMed ID: 27814991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of induced pluripotent stem cell line (ZZUi0016-A) from dermal fibroblasts of a normal human.
    Gao Y; Wang Y; Wang Z; Sun H; Zhang R; Yang J; Liu Y; Liu H; Zhang Q; Zhang S; Shi C; Xu Y; Song B
    Stem Cell Res; 2020 Mar; 43():101717. PubMed ID: 32007761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis of CHCHD2 in Canadian patients with familial Parkinson's disease.
    Zhang M; Xi Z; Fang S; Ghani M; Sato C; Moreno D; Liang Y; Lang AE; Rogaeva E
    Neurobiol Aging; 2016 Feb; 38():217.e7-217.e8. PubMed ID: 26639156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
    Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cells (iPSCs) derived from cerebrotendinous xanthomatosis (CTX) patient's fibroblasts carrying a R395S mutation.
    Höflinger P; Hauser S; Theurer Y; Weißenberger S; Wilke C; Schöls L
    Stem Cell Res; 2016 Sep; 17(2):433-436. PubMed ID: 27879219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis of CHCHD2 gene in Chinese familial Parkinson's disease.
    Liu Z; Guo J; Li K; Qin L; Kang J; Shu L; Zhang Y; Wei Y; Yang N; Luo Y; Sun Q; Xu Q; Yan X; Tang B
    Neurobiol Aging; 2015 Nov; 36(11):3117.e7-3117.e8. PubMed ID: 26343503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of gene-corrected iPSC line from Parkinson's disease patient iPSC line with alpha-SNCA A53T mutation.
    Lee SY; Jeong S; Kim J; Chung SK
    Stem Cell Res; 2018 Jul; 30():145-149. PubMed ID: 29906669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7.
    Chen ZT; Zhao ZH; Chen LN; Fan F; Cai GE; Weng HD; Wang YQ; Liao LM; Chen XC; Huang E; Ye QY
    Stem Cell Res; 2021 Mar; 51():102175. PubMed ID: 33485186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.